Botulinum toxin type B (Neurobloc): serious known risks

Source:
GOV UK
Publisher:
Medicines and Healthcare products Regulatory Agency
Publication date:
11 December 2014

Abstract

Risks such as toxin spread reported mostly with off-label use.